These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21737546)

  • 21. Aspirin attenuates podocyte injury in diabetic rats through overriding cyclooxygenase-2-mediated dysregulation of LDL receptor pathway.
    Ma KL; Liu L; Zhang Y; Wang GH; Hu ZB; Chen PP; Lu J; Lu CC; Gong TK; Gong YX; Liu BC
    Int Urol Nephrol; 2019 Mar; 51(3):551-558. PubMed ID: 30604228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semaphorin3a promotes advanced diabetic nephropathy.
    Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
    Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct roles for basal and induced COX-2 in podocyte injury.
    Cheng H; Fan X; Guan Y; Moeckel GW; Zent R; Harris RC
    J Am Soc Nephrol; 2009 Sep; 20(9):1953-62. PubMed ID: 19643929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
    Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
    Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
    Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
    Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
    J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Podocytes as a target of prorenin in diabetes.
    Sakoda M; Itoh H; Ichihara A
    Curr Diabetes Rev; 2011 Jan; 7(1):17-21. PubMed ID: 21067509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. eNOS deficiency predisposes podocytes to injury in diabetes.
    Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
    J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
    Zhang J; Fu H; Xu Y; Niu Y; An X
    J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
    Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury.
    Fujita Y; Tominaga T; Abe H; Kangawa Y; Fukushima N; Ueda O; Jishage KI; Kishi S; Murakami T; Saga Y; Kanwar YS; Nagai K; Doi T
    Sci Rep; 2018 Aug; 8(1):13011. PubMed ID: 30158674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of cyclooxygenase-2 predisposes to podocyte injury.
    Cheng H; Wang S; Jo YI; Hao CM; Zhang M; Fan X; Kennedy C; Breyer MD; Moeckel GW; Harris RC
    J Am Soc Nephrol; 2007 Feb; 18(2):551-9. PubMed ID: 17202413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.
    Zheng S; Carlson EC; Yang L; Kralik PM; Huang Y; Epstein PN
    J Am Soc Nephrol; 2008 Nov; 19(11):2077-85. PubMed ID: 18632844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formyl peptide receptor 1 promotes podocyte injury through regulation of mitogen-activated protein kinase pathways.
    Zhang J; Ding T; Tang D; Wang J; Huang P
    Exp Biol Med (Maywood); 2022 Jan; 247(2):87-96. PubMed ID: 34565207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.